1.Centers for Disease Control and Prevention. Immunization of health care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1997;46(RR-18):1–42.
2.Alter, MJ. The epidemiology of acute and chronic hepatitis C. Clinics in Liver Disease 1997;1:559–569.
3.Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998;47(RR-19):1–39.
4.Tokars, JI, Marcus, R, Culver, DH, et al. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. Ann Intern Med 1993;118:913–919.
5.Henderson, DK, Fahey, BJ, Willy, M, et al. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures: a prospective evaluation. Ann Intern Med 1990;113:740–746.
6.Gerberding, JL. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study. J Infect Dis 1994;170:1410–1417.
7.Ippolito, G, Puro, V, De Carli, G, Italian Study Group on Occupational Risk of HPV Infection. The risk of occupational human immunodeficiency virus infection in health care workers: Italian Multicenter Study. Arch Intern Med 1993;153:1451–1458.
8. Anonymous. HIV seroconversion after occupational exposure despite early prophylactic zidovudine therapy. Lancet 1993;341:1077–1078.
9.Lot, F, Abiteboul, D. Infections professionnelles par le V.I.N. en France chez le personnel de sante: le point au 30 juin 1995. Bulliten Epidemiologique Hebdomadaire (Paris) 1995.
10.Perdue, B, Wolderufael, D, Mellors, J, et al. HIV-1 transmission by a needlestick injury despite rapid initiation of four-drug postexposure prophylaxis. Presented at the 76th Conference on Retroviruses and Opportunistic Infections; January 31-February 4, 1999; Chicago, IL Abstract 210.
11.Beltrami, EM, Luo, C-C, Dela Torre, N, Cardo, DM. HIV transmission after an occupational exposure despite postexposure prophylaxis with a combination drug regimen. Presented at the 4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections in conjunction with the 10th Annual Meeting of the Society for Healthcare Epidemiology of America; March 5-9,2000; Atlanta, GA.
12.Beltrami, EM, Cheingsong, R, Respess, R, Cardo, DM, the Occupational HIV Exposure Study Group, CDC. Antiretroviral drug resistance in HIV-infected source patients for occupational exposures to healthcare workers. Presented at the 4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections in conjunction with the 10th Annual Meeting of the Society for Healthcare Epidemiology of America; March 5-9, 2000; Atlanta, GA.
13.Tack, PC, Bremer, JW, Harris, AA, Landay, AL, Kessler, HA, Kuritzkes, DR. Genotypic analysis of HIV-1 isolates to identify antiretroviral resistance mutations from source patients involved in health care worker occupational exposures. JAMA 1999;281:1085–1086.
14.Department of Labor, Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens: final rule. Federal Register 1991;56:64175–64182.
15. Pub L No. 106430, Needlestick Safety and Prevention Act (November 6, 2000).
16.Department of Labor, Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens; needlestick and other sharps injuries: final rule. Federal Register 2001;66:5318–5325.
17.Cardo, DM, Culver, DH, Ciesielski, CA. et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N Engl J Med 1997;337:1485–1490.
18.Centers for Disease Control and Prevention. Evaluation of safety devices for preventing percutaneous injuries among health-care workers during phlebotomy procedures: Minneapolis-St. Paul, New York City, and San Francisco, 1993-1995. MMWR 1997;46:21–25.
19.Mendelson, MH. Incidence and prevalence of needlesticks: an urban university hospital perspective. In: Using Safer Needle Devices: The Time Is Now, Report of the National Committee on Safer Needle Devices. Arlington, TX: J & J Medical; 1998.
20.Cardo, D, Culver, D, Srivastava, P, the NaSH Surveillance Group. Results from first phase of the National Surveillance System for Health Care Workers. Presented at the 7th Annual Meeting of the Society for Healthcare Epidemiology of America; April 27-29, 1997; St. Louis, MO.
21.Agresti, A. Categorical Analysis. New York: John Wiley & Sons; 1990:55–56.
22.Chiarello, L, Nagin, D, Laufer, F. Pilot Study of Needlestick Prevention Devices: Report to the Legislature. Albany, NY: New York State Department of Health; 1992.
23.Gershon, RRM, Pearse, L, Grimes, M, Flanagan, PA, Vlahov, D. The impact of multifocused interventions on sharps injury rates at an acute-care hospital. Infect Control Hosp Epidemiol 1999;20:806–811.
24.Billiet, LS, Parker, CR, Tanley, PC, Wallas, CH. Needlestick injury rate reduction during phlebotomy; a comparative study of two safety devices. Laboratory Medicine 1991;22:122–123.
25.Jagger, J. Reducing occupational exposure to bloodborne pathogens: where do we stand a decade later? Infect Control Hosp Epidemiol 1996;17:573–575.
26.Ippolito, G, De Carli, G, Puro, V, et al. Device-specific risk of needlestick injury in Italian health care workers. JAMA 1994;272:607–610.
27.Mendelson, MH, Chen, L, Solomon, R, Bailey, E, Kogan, G, McCarthy, D. Evaluation of a safety IV catheter. Presented at the 9th Annual Meeting of the Society for Healthcare Epidemiology of America; April 18-20, 1999; San Francisco, CA.
28.Mendelson, MH, Chen, L, Bailey, E, Finkelstein-Blond, L, Kogan, G. Evaluation of a safety IV catheter (IVC) (Becton Dickinson, Insyte Autoguard): final report. Presented at the 11th Annual Meeting of Society for Healthcare Epidemiology of America; March 31-April 1, 2001; Toronto, Ontario, Canada.
29.Centers for Disease Control and Prevention. Summary Report for Data Collected From June 1995 Through December 2000. Atlanta, GA: Centers for Disease Control and Prevention.
30.Centers for Disease Control and Prevention. Documented and possible occupationally acquired AIDS/HIV infection, by occupation. HIV/AIDS Surveillance Report. 2000; 12:24.
31.Ippolito, G, Puro, V, Heptonstall, J, Jagger, J, De Carli, G, Petrosillo, N. Occupational human immunodeficiency virus infection in health care workers: worldwide cases through September 1997. Clin Infect Dis 1999;28:365–383.
32.Campbell, SR, Srivastava, P, Williams, I, Alter, M, Cardo, D, NaSH Surveillance Group. Hepatitis C virus infection after occupational exposure. Presented at the 4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections and the 10th Annual Meeting of the Society for Healthcare Epidemiology of America; March 5-9, 2000; Atlanta, GA.
33.Chiarello, LA. Selection of needlestick prevention devices: a conceptual framework for approaching product evaluation. Am J Infect Control 1995;25:386–395.